Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Neogen Corporation (NEOG)

NMS · Medical Devices

$9.19-0.15 (-1.61%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$2.00B
P/E (TTM)
EPS
$-2.75
Div Yield
52W Range
$4.56–$11.43
Beta
1.79

Company overview

Next earnings: 2026-07-30(2d)

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Peers in Medical Devices

All in industry →

Recent press releases

April 2026

3 months ago8-KHealthcare

NEOGEN CORP — 8-K Filing

NEOGNEOGEN CORP

# 🧾 What This Document Is This is a **quarterly earnings report** (Form 8-K with an exhibit) for Neogen Corporation. It's like a "report card" for the company's third fiscal quarter, which ended on February 28, 2026. Companies are required to file these with the SEC to update investors on their fin

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

Neogen Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
144,502 sh-99.2%
6,864,470 sh● NEW
32,509,026 sh+1.5%
23,801,905 sh-0.7%
14,126 sh-99.6%
8,777,500 sh-37.6%
6,500,000 sh+30.0%

People at Neogen Corporation

All people →

Quarterly financials

Full financials →
Revenue trend
11/24
$83.3M
NI
02/25
$23.8M
NI
08/25
$209.2M
NI
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.17
Prior: $-0.05
Revenue sparkline